» Articles » PMID: 27720892

Carbon Monoxide Releasing Molecule Induces Endothelial Nitric Oxide Synthase Activation Through a Calcium and Phosphatidylinositol 3-kinase/Akt Mechanism

Overview
Date 2016 Oct 11
PMID 27720892
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The production of nitric oxide (NO) by endothelial NO synthase (eNOS) plays a major role in maintaining vascular homeostasis. This study elucidated the potential role of carbon monoxide (CO)-releasing molecules (CORMs) in NO production and explored the underlying mechanisms in endothelial cells. We observed that 25μM CORM-2 could increase NO production and stimulate an increase in the intracellular Ca level. Furthermore, ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetra acetic acid caused CORM-2-induced NO production, which was abolished by 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetraacetoxy-methyl ester (BAPTA-AM), indicating that intracellular Ca release plays a major role in eNOS activation. The inhibition of the IP3 receptor diminished the CORM-2-induced intracellular Ca increase and NO production. Furthermore, CORM-2 induced eNOS Ser phosphorylation and eNOS dimerization, but it did not alter eNOS expression. CORM-2 (25μM) also prolonged Akt phosphorylation, lasting for at least 12h. Pretreatment with phosphatidylinositol 3-kinase inhibitors (wortmannin or LY294002) inhibited the increases in NO production and phosphorylation but did not affect eNOS dimerization. CORM-2-induced eNOS Ser phosphorylation was intracellularly calcium-dependent, because pretreatment with an intracellular Ca chelator (BAPTA-AM) inhibited this process. Although CORM-2 increases intracellular reactive oxygen species (ROS), pretreatment with antioxidant enzyme catalase and N-acetyl-cysteine did not abolish the CORM-2-induced eNOS activity or phosphorylation, signifying that ROS is not involved in this activity. Hence, CORM-2 enhances eNOS activation through intracellular calcium release, Akt phosphorylation, and eNOS dimerization.

Citing Articles

Antioxidant and anticoagulant properties of myo-inositol determined in an ex vivo studies and gas chromatography analysis.

Rolnik A, Olas B, Szablinska-Piernik J, Lahuta L, Gromadzinski L, Majewski M Sci Rep. 2024; 14(1):25633.

PMID: 39465311 PMC: 11514185. DOI: 10.1038/s41598-024-76527-2.


Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?.

Arrigo E, Comita S, Pagliaro P, Penna C, Mancardi D Int J Mol Sci. 2023; 24(15).

PMID: 37569855 PMC: 10419417. DOI: 10.3390/ijms241512480.


The Triple Crown: NO, CO, and HS in cancer cell biology.

Oza P, Kashfi K Pharmacol Ther. 2023; 249:108502.

PMID: 37517510 PMC: 10529678. DOI: 10.1016/j.pharmthera.2023.108502.


Local delivery of gaseous signaling molecules for orthopedic disease therapy.

Sun J, Wang W, Hu X, Zhang X, Zhu C, Hu J J Nanobiotechnology. 2023; 21(1):58.

PMID: 36810201 PMC: 9942085. DOI: 10.1186/s12951-023-01813-6.


Wireless electrical stimulation at the nanoscale interface induces tumor vascular normalization.

Li C, Xiao C, Zhan L, Zhang Z, Xing J, Zhai J Bioact Mater. 2022; 18:399-408.

PMID: 35415302 PMC: 8965767. DOI: 10.1016/j.bioactmat.2022.03.027.